Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service
- PMID: 24474248
- DOI: 10.1001/jama.2014.148
Innovation, risk, and patient empowerment: the FDA-mandated withdrawal of 23andMe's Personal Genome Service
Comment in
-
Withdrawal of Personal Genome Service.JAMA. 2014 Jun 18;311(23):2441. doi: 10.1001/jama.2014.5570. JAMA. 2014. PMID: 24938573 No abstract available.
-
Withdrawal of Personal Genome Service--reply.JAMA. 2014 Jun 18;311(23):2441-2. doi: 10.1001/jama.2014.5584. JAMA. 2014. PMID: 24938574 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
